GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
13 hedge funds and large institutions have $50.5M invested in GW Pharmaceuticals Plc American Depositary Shares in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
89% more capital invested
Capital invested by funds: $26.6M → $50.5M (+$23.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less funds holding
Funds holding: 15 → 13 (-2)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$1.89M |
| 2 |
Millennium Management
New York
|
+$757K |
| 3 |
BC
Broadfin Capital
New York
|
+$608K |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$276K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$126K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.41M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$304K |
| 3 |
PIM
Partner Investment Management
San Francisco,
California
|
-$116K |
| 4 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$19.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |
GWPH Hedge Fund Activity: Q3 2013 in Review
13 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2013, worth a combined $50.5M — up 89% from $26.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GWPH and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was Redmile Group, opening a new position worth an estimated $1.89M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $3.41M sold.
- 13 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2013, down from 15 in Q2 2013.
- Funds reported $50.5M of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2013, up 89% quarter-over-quarter.
- 3 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2013 and 4 closed out, a net change of -1 holder.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2013 was Redmile Group, an estimated $1.89M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2013 was PFM Health Sciences, an estimated $3.41M sold.
Based on aggregated 13F filings for Q3 2013.